- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 323/24 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
Patent holdings for IPC class C07C 323/24
Total number of patents in this class: 12
10-year publication summary
|
0
|
0
|
1
|
0
|
0
|
1
|
2
|
0
|
3
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BioNTech SE | 838 |
3 |
| University Public Corporation Osaka | 302 |
2 |
| Bio-Xcelerator, Inc. | 20 |
2 |
| Novartis AG | 10169 |
1 |
| Mitsui Chemicals, Inc. | 3267 |
1 |
| Signum Dermalogix, Inc. | 13 |
1 |
| Dxgen Biosciences Co., Ltd. | 1 |
1 |
| Amphista Therapeutics Ltd | 26 |
1 |
| Other owners | 0 |